Zealand, Boehringer’s drug meets main weight-loss goal in mid-stage trial
By Ludwig Burger FRANKFURT (Reuters) – Zealand Pharma and partner
mid-stage
Pfizer starts mid-stage trial for vaccine against Omicron subvariant
(Reuters) – Pfizer Inc and its German partner BioNTech SE